Event Type
Disclosure
Voluntary
Variant
8-K
and Item 9.01 (including Exhibits 99.1 and 99.2) shall not be deemed “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “ Exchange Act
Other Events. Interim Phase 1a SAD/MAD Results The Interim Results announced in the press release are summarized below. The randomized, blinded, placebo-control
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Exhibit Description 99.1 Press Release, dated January 6, 2026. 99.2 Company Presentation, dat